NCT04569318View on ClinicalTrials.gov

A Study To Assess A Novel Form Of Cataract Treatment Using The Non-Invasive LEDINBIO Proof-Of-Concept Device

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 19, 2020

Primary Completion Date

August 19, 2021

Study Completion Date

September 9, 2021

Conditions
Cataract
Interventions
DEVICE

Treatment Beam

One of the subject's eyes will be treated with the treatment beam (20mW) up to 8 times for 15 minutes.

Trial Locations (1)

LV-1050

Dr.Solomatina Acu Centrs, Riga

Sponsors

Collaborators (1)

Onorach Clinical
All Listed Sponsors
collaborator

Onorach Clinical

UNKNOWN

lead

Edinburgh Biosciences Ltd

INDUSTRY

NCT04569318 - A Study To Assess A Novel Form Of Cataract Treatment Using The Non-Invasive LEDINBIO Proof-Of-Concept Device | Biotech Hunter | Biotech Hunter